| Variable | Control Group (n = 66) | Pump Thrombosis Group (n = 10) | P Value |
|---|---|---|---|
| Mean age, years ± SD | 57 ± 15 | 51 ± 11 | 0.259 |
| Male sex | 82% | 80% | 1.000 |
| Mean body mass index, kg/m2 | 29 ± 7 | 32 ± 7 | 0.318 |
| Etiology of heart failure | 1.000 | ||
| Ischemic | 36 (55%) | 5 (50%) | |
| Nonischemic | 30 (45%) | 5 (50%) | |
| Indication for LVAD implantation | 0.299 | ||
| Bridge to transplant | 28 (42%) | 2 (20%) | |
| Destination therapy/other | 38 (58%) | 8 (80%) | |
| Hematologic disorder | 1 (2%) | 0 (0%) | 1.000 |
| Duration of device support, days | 0.734 | ||
| Median | 201 | 327 | |
| 25th-75th IQR | 59-602 | 181-509 | |
| Range | 2-1,470 | 44-2,036 |
IQR, interquartile range; LVAD, left ventricular assist device.